In conclusion, our data support, for the first time, a crucial role of PPARα in regulating the metabolic switch that allows GSCs to survive in O2 and nutrient limitations and demonstrate the effectiveness of GW6471 as anti-tumor and lipid/glucose storage-reducing drug. The gene discussed is PPARA; the disease is neoplasm.